Earn CME: https://www.naccme.com/program/19-cpc-101-5 This webcast features a presentation by Dr. Atish D. Choudhury that examines the latest clinical safety and efficacy data surrounding next-generation antiandrogen agents for initial treatment of localized hormone-sensitive prostate cancer (HSPC). © 2019 NACCME, an HMP Company
Prostate Cancer: Clinical Guidelines, Novel Therapies, and Therapeutic Uncertainty
